Healthia Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Healthia.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	19.8%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Sep 17

Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

Sep 01

I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Aug 17

Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

May 19

Is Healthia (ASX:HLA) A Risky Investment?

Apr 19

With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Apr 03

Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Mar 19

Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

Mar 06

What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Feb 26

Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Feb 09

Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 19

Why Dividend Hunters Love Healthia Limited (ASX:HLA)

Dec 29

Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?

Dec 10

We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings

Nov 20

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Healthia no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

ASX:HLA - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2023	253	5	15	23	N/A
3/31/2023	242	3	14	20	N/A
12/31/2022	232	1	12	18	N/A
9/30/2022	216	-1	13	18	N/A
6/30/2022	200	-3	14	17	N/A
3/31/2022	184	-2	13	16	N/A
12/31/2021	168	0	12	15	N/A
9/30/2021	152	3	18	21	N/A
6/30/2021	137	5	23	26	N/A
3/31/2021	121	6	26	28	N/A
12/31/2020	105	7	29	31	N/A
9/30/2020	96	5	22	24	N/A
6/30/2020	87	3	16	17	N/A
3/31/2020	83	1	9	10	N/A
12/31/2019	79	0	2	3	N/A
9/30/2019	72	0	-1	1	N/A
6/30/2019	65	-1	-4	-2	N/A
3/31/2019	57	-2	-3	0	N/A
12/31/2018	48	-3	-1	2	N/A
9/30/2018	41	-2	-1	1	N/A
6/30/2018	34	-2	0	1	N/A
6/30/2017	67	4	N/A	N/A	N/A
6/30/2016	67	4	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de HLA es superior a la tasa de ahorro (2.1%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de HLA crezcan más rápidamente que el mercado Australian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de HLA crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de HLA crezcan más rápidamente que el mercado de Australian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de HLA crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de HLA se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Healthia Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 20% to AU$1.80

Price target decreased by 8.1% to AU$2.26

Price target decreased to AU$2.36

Consensus EPS estimates fall by 55%

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Consensus EPS estimates fall by 70%

Recent updates

Healthia Limited Announces Board Changes

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 20% to AU$1.80

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

New major risk - Financial position

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Price target decreased by 8.1% to AU$2.26

Healthia Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.03 (vs AU$0.001 loss in 1H 2022)

Healthia Limited (ASX:HLA) agreed to acquire Kosmac & Clemens Optometrists.

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Calculating The Fair Value Of Healthia Limited (ASX:HLA)

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought AU$85k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of Corio Bay Health Group.

Less than half of directors are independent

Healthia Limited (ASX:HLA) acquired Watsonia Physiotherapy.

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Healthia Limited, Annual General Meeting, Nov 23, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Corio Bay Health Group.

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Healthia Limited Determines Not to Declare the Payment of A Final Dividend for 2022

Price target decreased to AU$2.36

Healthia Limited to Report Fiscal Year 2022 Results on Aug 31, 2022

Consensus EPS estimates fall by 55%

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Healthia Limited Announces Board Changes

Board Member recently sold AU$52k worth of stock

Consensus EPS estimates fall by 70%

First half 2022 earnings: EPS and revenues miss analyst expectations

Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02

Healthia Limited Announces Dividend on HLA - ORDINARY FULLY PAID for the Six Months Ended 31 Dec. 2021, Payable on 24 March 2022

Healthia Limited Recommends Interim Dividend, Payable on March 22, 2022

Healthia Limited to Report First Half, 2022 Results on Feb 28, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Mornington Peninsula Family Physiotherapy.

Board Member recently bought AU$64k worth of stock

Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise

Price target increased to AU$2.55

Healthia Limited has completed a Follow-on Equity Offering in the amount of AUD 22.268376 million.

Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%

Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Investor sentiment improved over the past week

Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.043 in FY 2020)

Investor sentiment improved over the past week

I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire John Holme Optometrist Mareeba.

Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

Healthia Limited (ASX:HLA) agreed to acquire The Eyecare Place for AUD 0.62 million.

Is Healthia (ASX:HLA) A Risky Investment?

With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Healthia Limited (ASX:HLA) completed the acquisition of Sandringham Sports Physio.

Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

Independent Non-Executive Director recently bought AU$96k worth of stock

First half 2021 earnings released: EPS AU$0.071 (vs AU$0.011 in 1H 2020)

Revenue beats expectations

Healthia Limited (ASX:HLA) acquired 4 physiotherapy clinics for AUD 1.3 million.

What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Healthia Limited (ASX:HLA) completed the acquisition of The Physio Clinic for AUD 2 million.

Investor sentiment improved over the past week

New 90-day high: AU$1.90

Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Investor sentiment improved over the past week